: iStockAnalyst.com Symbols Feed

Celgene: Blockbuster Biotech Bet

Mon, 10 Nov 2008 14:18:00 GMT

"The medical arena has long been my favorite sectors; perhaps the best opportunities within the medical sector will be with companies who provide life-saving products for the treatment of serious diseases," says Dave Dyer. In The Dave Dyer Newsletter, he explains "That is why Celgene (NASDAQ: CELG) is an excellent choice in this economy." Here's his look at this recession-resistant[More...]

A List of Best Performing Stocks Year to Date

Tue, 27 May 2008 01:16:00 GMT

Since we have a break in the action here, instead of doing our normal best performing stocks of the week (not many made the list this week due to a poor market), this is a good time to look at what is performing best so far this year. Further, due the composition of the list and with many of these stocks due for a correction it's probably worthwhile to take a look now, as things might change relatively soon. We looked at a similar list in early November (Nov 4: How to Make 75% in 3 Months) when the list was dominated by large cap Chinese stocks, a few big cap tech stocks, Indian stocks, and fertilizer. Except for fertilizer most of those groups stunk for the better part of the following 5 months, and hence "returned to the mean". However, the list did turn out a few gems we jumped on, so looking at such lists helps us to identify what has been working and what other[More...]

Will Synta Break A 30 Year Old Record?

Sun, 27 Apr 2008 19:59:26 GMT

For the first part of this article click here.[More...]

Biotechs Coming Alive:

Tue, 15 Apr 2008 06:11:24 GMT

The market was stronger today, boosted by a rally in the biotech sector. The agricultural stocks also continued to show strength. In addition, steel stocks displayed solid performances. The Dow was up +54.72 points; SPX added +6.06 points; and Nasdaq gained +29.58 points. Here’s how the market looked at the close:BTK (biotech) jumped +4.81%, while INX2 (internet) and SOX (semiconductors) made modest gains. HGX (housing) added +1.14%, but XLF (finan[More...]

Media Digest for 4/14

Mon, 14 Apr 2008 14:28:36 GMT

Submitted by Optiondragon[More...]

Media Digest for 4/11

Fri, 11 Apr 2008 13:54:21 GMT

Submitted By Optiondragon[More...]

What to do with the Biotech sector?

Fri, 11 Apr 2008 05:45:56 GMT

The major indices closed with modest gains today after investors digested the March retail sales and were willing to put money back into the sector.[More...]

Analyst Comments: XL Capital, Sinopec, SCOR Group, Cleveland-Cliff, Dell, Millennium Pharma, Theravance

Fri, 11 Apr 2008 05:35:32 GMT

XL Capital Ltd. (XL) is expected to release its 1Q08 results on April 22, 2008, with a conference call scheduled the next day. XL's 4Q07 results missed expectations as a result of impacted of $41.5 billion in losses and write downs related to its operatin[More...]

Observations and Stocks for Friday - Apr 11 2008 12:51AM

Fri, 11 Apr 2008 04:45:46 GMT

The interview of the day is with Dmitry Medvedev. Russia’s president-elect talks in depth with FT editor Lionel Barber about the social and economic course for Russia.[More...]

Biotechs Coming Alive: SPX, Nasdaq, MLNM, AMGN, OSIP, IMCL, PDLI, DNA, XBI, IBB, MTL

Fri, 11 Apr 2008 01:11:29 GMT

The market was stronger today, boosted by a rally in the biotech sector. The agricultural stocks also continued to show strength. In addition, steel stocks displayed solid performances.[More...]

Takeda Incurs 1st Profit Fall in 4 Years in FY 2008

Mon, 11 May 2009 14:47:00 GMT

May 11--TOKYO -- Takeda Pharmaceutical Co. said Monday it posted a group net profit of 234.39 billion yen in fiscal 2008 ended in March, down 34.1 percent from the previous year in the first profit fall in four years.
Takeda attributed the result to large costs related to its acquisition of U.S. biotechnology-based drug firm Millennium Pharmaceuticals Inc. in May last year.
Sales grew 11.9 percent to 1.54 trillion yen due in part to the addition of Millennium to the Takeda group, said the leading Japanese drugmaker.

[More...]

Takeda Completes Acquisition of Millennium - May 27 2008 12:42AM

Wed, 14 May 2008 17:16:00 GMT

Takeda Pharmaceutical Company Limited and Millennium Pharmaceuticals, Inc. today announced the completion of Takeda's acquisition of Millennium for US$25.00 per share in cash. Takeda completed the acquisition through a tender offer and subsequent merger of a wholly-owned subsidiary of Takeda into Millennium. Millennium is now a wholly-owned subsidiary of Takeda.[More...]

Takeda Completes Subsequent Offering Period for Shares of Millennium Pharmaceuticals, Inc. - May 27 2008 12:42AM

Wed, 14 May 2008 10:56:00 GMT

Takeda Pharmaceutical Company Limited , and Millennium Pharmaceuticals, Inc. , today announced the completion of Takeda's tender offer by its wholly-owned subsidiary, Mahogany Acquisition Corp., to acquire all outstanding shares of Millennium common stock for US$25.00 per share.[More...]

New Analyst Reports for GILEAD SCIENCES INC, ISIS PHARMACEUTICALS INC, CURIS INC, and MILLENNIUM PHARMACEUTICALS INC - May 27 2008 1:18AM

Fri, 09 May 2008 18:01:00 GMT

New Analyst Reports for GILEAD SCIENCES INC, ISIS PHARMACEUTICALS INC, CURIS INC, and MILLENNIUM PHARMACEUTICALS INC[More...]

Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period - Jun 2 2008 1:05AM

Fri, 09 May 2008 06:17:00 GMT

Takeda Pharmaceutical Company Limited, "Takeda", and Millennium Pharmaceuticals, Inc., "Millennium" today announced the successful completion of Takeda's cash tender offer by its wholly-owned subsidiary, Mahogany Acquisition Corp., to acquire all outstanding shares of Millennium common stock for US$25.00 per share.[More...]

Mergent, Inc. Announces Changes to the HealthShares(TM) Composite, Enabling Technologies, Autoimmune-Inflammation, Cancer, Cardiology and Neuroscience Indexes - Jun 1 2008 5:29PM

Tue, 06 May 2008 19:56:00 GMT

Mergent, Inc., administrator for the Healthshares Indexes, a series of 20 underlying indexes for the HealthShares Exchange Traded Funds, today announced the following changes with effect from the opening of trade on Friday, May 9, 2008: Masimo Corporation will replace Millennium Pharmaceuticals Inc in the HealthShares Composite Index, Quest Diagnostics Inc will replace Millennium Pharmaceuticals Inc in the HealthShares Enabling Technologies Index, Actelion will replace Millennium Pharmaceuticals Inc in the HealthShares Autoimmune-Inflammation Index, Fresenius SE will replace Millennium Pharmaceuticals Inc in the HealthShares Cancer Index, Actelion will replace Millennium Pharmaceuticals Inc in the HealthShares Cardiology Index, and Schwarz Pharma AG will replace Millennium Pharmaceuticals Inc in the HealthShares Neuroscience Index. Millennium is being acquired by Takeda Pharmaceutical Company Limited through a cash tender offer.[More...]

Standard & Poor's Announces Changes to U.S. Indices - 05-05-08 - May 27 2008 1:38AM

Mon, 05 May 2008 21:38:00 GMT

Standard & Poor's will make the following changes to the S&P MidCap 400 and S&P SmallCap 600:[More...]

Takeda and Millennium Announce Early Termination of Hart-Scott-Rodino Waiting Period

Tue, 29 Apr 2008 10:56:00 GMT

Takeda Pharmaceutical Company Limited and Millennium Pharmaceuticals, Inc. today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart- Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with the previously announced merger agreement between Takeda and Millennium.[More...]

Market Pulse Breaking News Alert for Tuesday, April 15, 2008: NCEN - Nacel Energy Deploys Advanced Wind Assessment Systems at Blue Creek and Channing Flats Power Projects!

Tue, 15 Apr 2008 12:25:00 GMT

Market Pulse News Alert for this AM, Stocks to Watch are: NACEL Energy Corporation , Circuit City Stores Inc. , Millennium Pharmaceuticals Inc. and Spongetech Delivery Systems Inc. .[More...]

Takeda Commences Cash Tender Offer for all Outstanding Shares of Millennium

Fri, 11 Apr 2008 20:15:00 GMT

Takeda Pharmaceutical Company Limited today announced the commencement of its cash tender offer for all outstanding shares of the common stock of Millennium Pharmaceuticals, Inc. for US$25.00 per share. The tender offer is being made by Mahogany Acquisition Corp., a wholly owned subsidiary of Takeda America Holdings, Inc., which is a wholly owned subsidiary of Takeda, pursuant to an Offer to Purchase, dated April 11, 2008, and the Agreement and Plan of Merger , dated as of April 10, 2008, by and among Takeda America Holdings, Inc., Mahogany Acquisition Corp., and Millennium. Takeda is also a party to the Merger Agreement for certain purposes.[More...]

BellwetherReport.com Free Analyst Review for MLNM, VMED, FCSX, and APOG

Thu, 10 Apr 2008 14:37:00 GMT

BellwetherReport.com is the leading online financial newsletter for investors seeking top independent and unbiased research. Investors seeking free and unbiased research on the companies mentioned in this release are encouraged to sign up to www.bellwetherreport.com for a free subscription to access these reports. Today, we have scheduled interviews with a number of the top analysts in North America to speak with them in regards to the current market activity and position of Millennium Pharmaceuticals , Virgin Media , FCStone Group and Apogee Enterprises .[More...]